CompletedNCT00067262
Extended-release valproate for mania in young people with bipolarity
About this title
An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
Read the official source — NCT00067262Medication studyAges 10–17United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
- Listed locations
- Stanford and 15 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMarch 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 150
- Sponsor
- Abbott
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 10 Years to 17 Years
- Official registry ID
- NCT00067262
- Official title
Show the full official title
A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Depakote ER for the Treatment of Bipolar Disorder in Children and Adolescents
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Stanford · Washington D.C. · Altamonte Springs
13 more locations
- Miami
- North Miami
- Boise
- Libertyville
- Newton
- Lexington
- New Orleans
- Shreveport
- Clinton Township
- Chesterfield
- Oklahoma City
- Galveston
- Houston
Questions about this study
Who is behind this study?
The study sponsor is Abbott.
Did this study involve medication?
Yes. The study involved medication, including Divalproex Sodium Extended-Release Tablets.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 10 years to 17 years. Other eligibility criteria applied.
